Market revenue in 2023 | USD 6,161.6 million |
Market revenue in 2030 | USD 13,249.6 million |
Growth rate | 11.6% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Liquid Oral |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Liquid Oral, Powder In Sachet / Jar, Gummies, Energy Bars, Other suitable forms (Diskettes, etc.) |
Key market players worldwide | Ashland Inc, Glanbia PLC, Herbalife Ltd, Menadiona, Twinlab Consolidated Holdings Inc, Nutrivo, Gemini Pharmaceuticals, Rain Nutrience |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nutraceutical contract manufacturing services market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 25.27% in 2023. Horizon Databook has segmented the Germany nutraceutical contract manufacturing services market based on tablets, capsules, liquid oral, powder in sachet / jar, gummies, energy bars, other suitable forms (diskettes, etc.) covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is one of the key contributors to the nutraceutical contract manufacturing services market growth in Europe. Growth in the country is due to the increasing demand for nutritional supplements. In addition, the growing interest in preventative healthcare & achieving well-being via nutrition and increasing healthcare spending are expected to fuel market growth.
Furthermore, growing awareness of aesthetics and increasing disposable income in the country is another factor responsible for market growth. According to the Organization for Economic Co-operation and Development (OECD), the average household net adjusted income available per capita in Germany was estimated to be USD 34,297 annually.
Some key players in Germany nutraceutical contract manufacturing services market are Lufapak GmbH, Vital Products GmbH, Goerlich Pharma GmbH, and Amapharm GmbH. Moreover, some of the key players in Germany are extensively investing in expanding their manufacturing facilities, accelerating market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany nutraceutical contract manufacturing services market , including forecasts for subscribers. This country databook contains high-level insights into Germany nutraceutical contract manufacturing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account